The Center for Biologics Evaluation and Research (CBER) regulates vaccine products.

Center for Biologics Evaluation and Research (blood, vaccines)

The FDA Centers for Biologics Evaluation & Research maintains the information on each recalled or withdrawn product.

Karen Midthun, MD, director, FDA's Center for Biologics Evaluation and Research.

Research at the Center for Biologics Evaluation and Research (CBER)

Some biological products are also legally considered drugs, but they are covered by the Center for Biologics Evaluation and Research.

The Center for Biologics Evaluation and Research (CBER) is responsible for ensuring the safety and efficacy of the biological products.

Search Research In order to provide effective regulatory review of biological products, the Center for Biologics Evaluation and Research conducts active mission-related research programs.

The biologics division, known formally as the Center for Biologics Evaluation and Research, will retain jurisdiction over blood products, vaccines, tissue transplants and gene therapy.

You can make initial notifications of transfusion-related fatalities and donation-related deaths to FDA's Center for Biologics Evaluation and Research.